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Estimated Timing of the Last Common Ancestor 
of the SARS Coronavirus
to the editor: Using the viral sequences derived
from clinical specimens collected in Hong Kong
between February and April 2003 from 139 patients
with the severe acute respiratory syndrome (SARS),1
we attempted to estimate the timing of the last com-
mon ancestor of the coronavirus associated with
the recent outbreaks of SARS. We previously report-
ed the results of phylogenetic analysis, using the
same set of spike-gene sequences as that in the
SARS-associated coronavirus (SARS-CoV) isolated
during the early phase of the outbreak (February to
April) in Hong Kong and southern China, together
with those available in the public data base.1
Assuming that the mutation rate was uniform,
we carried out a linear regression analysis that was
similar to the approach used for the timing of the
origin of human immunodeficiency virus type 1.2
The divergence (i.e., branch length), based on the
genetic distance between the isolates and the root
of the phylogram, was plotted as a function of the
sampling time (Fig. 1).2,4 The root was defined as
the first diverging point2 of the hypothetical com-
mon ancestor of SARS-CoV. The best-fit line was
generated by the linear regression analysis extrap-
olated back to the past. The divergence of the se-
quences from the common ancestor was found to
have a linear relation with time (P<0.001), in a pro-
gressive manner. The last appearance of the com-
mon ancestor of SARS-CoV was estimated to be on
December 12, 2002 (95 percent confidence inter-
val, September 26, 2002, to January 13, 2003), when
the value of the divergence was zero. This finding
suggests that the first deviation of the ancestral vi-
rus may have occurred in late 2002, close to the time
of the first reports of SARS in southern China.5
Although additional sampling of sequences, in-
volving a longer time frame, is needed, the current
findings shed some light on the origin of SARS-CoV
and thus may help elucidate its evolution.
Figure 1. Timing of the Most Recent Common Ancestor of the Hong Kong 
SARS-CoV.
The divergence of the sequence from the ancestral sequence was plotted 
against sampling time (GraphPad Prism, version 4.00).3 The red line repre-
sents the best-fit line obtained by linear regression analysis, and the blue lines 
indicate the 95 percent confidence intervals.
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